Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors

Clinical trial NCT04023669 · COMPLETED

Trial details

NCT number: NCT04023669
Sponsor: St. Jude Children's Research Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain Tumor Brain Tumor, Recurrent Brain Tumor, Refractory Brain Tumor, Pediatric Medulloblastoma Medulloblastoma Recurrent Medulloblastoma, Non-WNT/Non-SHH Medulloblastoma, Non-WNT/Non-SHH, Group 3 Medulloblastoma, Non-WNT/Non-SHH, Group 4 Brain Cancer CNS Cancer CNS Tumor

Start date: 2019-08-08
Primary completion: 2023-05-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.